Home › Stocks › MLTX › All Fund Holders
MLTX — MOONLAKE IMMUNOTHERAPEUTICS · All Fund Holders
Funds holding (latest): 36 · Reported value held: $378.84M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| D. E. Shaw & Co history | Q2 2026 | 3.37M | $65.53M | 0.03% | Add |
| Janus Henderson Group history | Q1 2026 | 3.45M | $64.30M | 0.03% | Add |
| Two Sigma Investments history | Q2 2026 | 1.72M | $33.40M | 0.03% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 1.39M | $27.60M | 0.00% | New |
| Point72 Asset Management history | Q2 2026 | 1.16M | $22.56M | 0.09% | Reduce |
| BlackRock Inc history | Q2 2026 | 1.09M | $21.32M | 0.00% | Add |
| Balyasny Asset Management history | Q2 2026 | 912.72K | $17.77M | 0.02% | Reduce |
| Bank of America Corp history | Q2 2026 | 751.90K | $14.64M | 0.00% | Add |
| Arrowstreet Capital history | Q2 2026 | 750.78K | $14.62M | 0.01% | Add |
| Renaissance Technologies history | Q2 2026 | 643.27K | $12.52M | 0.02% | Add |
| Millennium Management history | Q2 2026 | 636.19K | $12.39M | 0.01% | Add |
| Morgan Stanley history | Q2 2026 | 563.60K | $10.97M | 0.00% | Reduce |
| Marshall Wace history | Q2 2026 | 550.35K | $10.72M | 0.01% | Add |
| Casdin Capital history | Q1 2026 | 450.00K | $8.39M | 0.64% | New |
| AQR Capital Management history | Q2 2026 | 358.88K | $6.99M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 328.52K | $6.40M | 0.00% | Add |
| Soros Fund Management history | Q4 2023 | 100.00K | $6.04M | 0.11% | Add |
| Citadel Advisors history | Q2 2026 | 211.80K | $4.12M | 0.01% | Reduce |
| Vanguard Group history | Q4 2025 | 266.15K | $3.51M | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 143.56K | $2.80M | 0.00% | Hold |
| Invesco Ltd history | Q1 2026 | 139.57K | $2.60M | 0.00% | New |
| Goldman Sachs Group history | Q2 2026 | 129.43K | $2.52M | 0.00% | Reduce |
| Manulife Financial history | Q2 2026 | 109.58K | $2.13M | 0.00% | Reduce |
| Geode Capital Management history | Q2 2026 | 74.76K | $1.45M | 0.00% | Add |
| Wellington Management Group history | Q2 2025 | 21.39K | $1.01M | 0.00% | Reduce |
| Northern Trust Corp history | Q2 2026 | 45.66K | $889.00K | 0.00% | Add |
| Principal Global Investors history | Q3 2025 | 70.94K | $508.66K | 0.00% | New |
| Legal & General Investment Management America history | Q2 2026 | 21.04K | $409.73K | 0.00% | Add |
| Franklin Resources history | Q3 2025 | 33.58K | $240.75K | 0.00% | New |
| Farallon Capital Management history | Q4 2023 | 3.40K | $205.33K | 0.00% | New |
| Wells Fargo & Co history | Q2 2026 | 10.00K | $194.70K | 0.00% | Reduce |
| Deutsche Bank AG history | Q2 2026 | 2.89K | $56.23K | 0.00% | Add |
| Citigroup Inc history | Q2 2026 | 1.36K | $26.44K | 0.00% | Reduce |
| T. Rowe Price Associates history | Q2 2026 | 1.04M | $20.28K | 0.00% | Reduce |
| PNC Financial Services history | Q2 2026 | 24 | $468 | 0.00% | Add |
| Amundi US history | Q1 2025 | 12 | $457 | 0.00% | Hold |